Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Travoprost vs. latanoprost for glaucoma or ocular hypertension in Japanese subjects
NCT00047593Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jan 2000
- Primary completion
- Jul 2004
- Modality
- Prodrugs/Conditional Activator Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of travoprost in open-angle glaucoma (OAG), ocular hypertension, sponsored by Alcon Inc.. Started Jan 2000; status: completed.
02
Drugs
travoprost
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT00047593.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047593.